Company intelligence / Profile preview

ENLASO

San Francisco, CA, USA

Ownership: Private
Development stage: Other

Overview

ENLASO was a specialized language service provider (LSP) that focused on the life sciences, healthcare, and pharmaceutical sectors. The company provided comprehensive translation, localization, and linguistic quality assurance services for clinical trial protocols, regulatory filings, and medical device documentation. ENLASO was recognized for its technical expertise and its commitment to open-source localization tools, such as the Okapi Framework. In 2016, ENLASO was acquired by Moravia (now part of RWS) to bolster its specialized life sciences division.

Industry: Consulting

Beyond the preview

Go deeper on ENLASO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ENLASO.

Explore the full profile